Pune's Gennova Biopharmaceuticals developing COVID-19 vaccine for Omicron variant

Pune's Gennova Biopharmaceuticals is developing an Omicron-specific COVID-19 vaccine, a company spokesperson said on Monday. The pharmaceutical manufacturer has already filed its phase 2 data with Central Drugs Standard Control Organisation (CDSCO) on Friday, the spokesperson added.

Related Keywords

India ,Hubspot ,Gennova Biopharmaceuticals Limited ,Government Of India National Regulatory Authority ,Central Drugs Standard Control Organisation ,Reuters ,Vaccine Subject Expert Committee ,Gennova Biopharmaceuticals ,Drug Controller General ,National Regulatory Authority ,Pune ,Omicron Variant ,